GE HealthCare Technologies Inc. $GEHC Shares Sold by Baird Financial Group Inc.

Baird Financial Group Inc. reduced its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 19.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 113,843 shares of the company's stock after selling 27,901 shares during the period. Baird Financial Group Inc.'s holdings in GE HealthCare Technologies were worth $7,287,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in GEHC. NBH Bank purchased a new stake in shares of GE HealthCare Technologies during the second quarter worth about $26,000. Godfrey Financial Associates Inc. acquired a new stake in GE HealthCare Technologies in the 4th quarter worth approximately $27,000. Physician Wealth Advisors Inc. grew its position in GE HealthCare Technologies by 60.4% during the 1st quarter. Physician Wealth Advisors Inc. now owns 433 shares of the company's stock worth $31,000 after purchasing an additional 163 shares during the last quarter. MV Capital Management Inc. purchased a new stake in GE HealthCare Technologies during the 4th quarter worth approximately $33,000. Finally, Hilton Head Capital Partners LLC acquired a new position in GE HealthCare Technologies during the 4th quarter valued at approximately $34,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Trading Up 0.5%

Shares of GE HealthCare Technologies stock opened at $64.25 on Tuesday. The company has a market cap of $29.02 billion, a P/E ratio of 14.74, a price-to-earnings-growth ratio of 1.69 and a beta of 0.70. The firm has a 50-day simple moving average of $68.35 and a two-hundred day simple moving average of $68.18. The company has a debt-to-equity ratio of 0.92, a quick ratio of 0.97 and a current ratio of 1.26. GE HealthCare Technologies Inc. has a fifty-two week low of $58.75 and a fifty-two week high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings data on Wednesday, July 29th. The company reported $1.13 EPS for the quarter, beating analysts' consensus estimates of $1.04 by $0.09. GE HealthCare Technologies had a return on equity of 20.12% and a net margin of 9.33%.The business had revenue of $5.29 billion during the quarter, compared to analysts' expectations of $5.26 billion. During the same period in the previous year, the business earned $1.06 earnings per share. The business's revenue was up 5.8% compared to the same quarter last year. As a group, equities analysts predict that GE HealthCare Technologies Inc. will post 4.93 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 14th. Investors of record on Friday, July 24th were paid a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend was Friday, July 24th. GE HealthCare Technologies's dividend payout ratio is currently 3.21%.

Analysts Set New Price Targets

GEHC has been the subject of a number of research analyst reports. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of GE HealthCare Technologies in a report on Wednesday, August 12th. Royal Bank Of Canada began coverage on GE HealthCare Technologies in a research report on Tuesday, June 23rd. They issued an "outperform" rating and a $80.00 target price on the stock. Evercore restated an "outperform" rating and issued a $84.00 target price on shares of GE HealthCare Technologies in a research note on Thursday, July 30th. BMO Capital Markets started coverage on GE HealthCare Technologies in a research report on Wednesday, July 8th. They set a "market perform" rating and a $70.00 price target for the company. Finally, Wells Fargo & Company boosted their price target on GE HealthCare Technologies from $75.00 to $85.00 and gave the company an "overweight" rating in a research note on Thursday, July 30th. Ten research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company's stock. According to MarketBeat, GE HealthCare Technologies presently has a consensus rating of "Hold" and a consensus price target of $77.73.

About GE HealthCare Technologies

GE HealthCare Technologies Inc is a global medical technology, pharmaceutical diagnostics and digital solutions company headquartered in Chicago, Illinois. The company provides products and services designed to support healthcare providers across diagnostic imaging, clinical care and treatment planning.

Its portfolio includes imaging systems such as magnetic resonance imaging, computed tomography, molecular imaging, X-ray and surgical imaging equipment. GE HealthCare also offers ultrasound systems, patient monitoring and care solutions, anesthesia delivery and respiratory care products, maternal and infant care technologies, and healthcare information technology.

The company's Pharmaceutical Diagnostics business develops and supplies contrast media and radiopharmaceuticals used to enhance medical imaging and support the detection and monitoring of disease.

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.